Using 3D Imaging of Prostate Biopsies to Find High-Risk Patients Sooner
3D Spatial Biology of Prostate Cancer Biopsies For Earlier Identification of High Risk Patients
This project is developing a new 3D imaging tool to help doctors better predict which prostate cancer patients might develop more serious disease.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Alpenglow Biosciences, INC. NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11135597 on NIH RePORTER |
What this research studies
Current methods sometimes struggle to tell which prostate cancers will spread, leading to advanced disease in some patients. This project aims to improve predictions by using a special 3D imaging platform on prostate biopsy samples. Researchers are working to make the sample preparation faster and more automatic, and they are building artificial intelligence models to analyze the 3D images. The goal is to create a comprehensive model that can predict the risk of prostate cancer spreading.
Who could benefit from this research
Good fit: This work is relevant for patients diagnosed with localized prostate cancer who need better tools to understand their risk of the disease spreading.
Not a fit: Patients whose prostate cancer has already spread or those without a prostate cancer diagnosis would not directly benefit from this specific diagnostic tool.
Why it matters
Potential benefit: If successful, this technology could help identify high-risk prostate cancer patients earlier, allowing for more timely and effective treatment before the cancer spreads.
How similar studies have performed: The underlying 3D spatial biology platform has been featured in publications and is compatible with existing lab procedures, suggesting a foundation for this advanced application.
Where this research is happening
Seattle, United States
- Alpenglow Biosciences, INC. — Seattle, United States (Active)
Researchers
- Principal investigator: Reder, Nicholas — Alpenglow Biosciences, INC.
- Study coordinator: Reder, Nicholas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.